MannKind | 营业费用

Operating Expenses 更改 日
Adma Biologics USD 85.84M 27.26M 2023-12
Dynavax Technologies USD 64.09M 311K 2023-12
Halozyme Therapeutics USD 129M 1.25M 2023-12
Insmed USD 261.96M 35.22M 2023-12
MannKind USD 50.61M 4.46M 2023-12
Novo Nordisk DKK 31.82B 1.41B 2023-09
Xencor USD 79.7M 2.27M 2023-12



MannKind 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.